AI joins the fight: using scans and blood tests to personalize kidney cancer care
NCT ID NCT05782400
Summary
This study aims to find better ways to match patients with newly diagnosed metastatic kidney cancer to the most effective first treatment. Researchers will collect blood, tumor tissue, and CT scans from 100 patients to look for patterns. They will use computer analysis to try to predict which patients will respond best to different available drug combinations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CLEAR CELL RENAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Tumori
Milan, Mi, 20156, Italy
Conditions
Explore the condition pages connected to this study.